Please login to the form below

Not currently logged in
Email:
Password:

NDA Group appoints Alison McGregor as its principal consultant

She joins the group following a new US office launch

Drug development consultancy, NDA Group, has appointed Alison McGregor as its principal consultant following the opening of its new US office in San Francisco.

McGregor joins the group from BioMarin Pharmaceuticals, where she was previously global regulatory affairs leader.

She has over 20 years’ experience in the pharmaceutical sector working for both industry and regulatory agencies including AstraZeneca and the UK’s MHRA.

Johan Stromquist, chief executive officer, NDA Group, said: “The US expansion is our main focus in 2018 and we are planning expanding our support for FDA and EMA submissions, milestone meetings and de-risking early stage data packages.

“Bringing Alison on-board is particularly important as her experience represents the ideal we share across NDA – that of bringing diverse regulatory requirements together to create the best possible development programmes as efficiently as possible.”

24th November 2017

From: Marketing

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Wiley

Wiley is a global leader in research and education. We clear the path for seekers of knowledge, leading the way...

Latest intelligence

The importance of accelerating clinical trial diversity
Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
Digital Opinion Leaders: The Role of Influencers in Medical Communications
There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
Creating Hope Though Action – World Suicide Prevention Day
At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....